Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Annals of Epidemiology|July 9, 2010
Design and implementation of the Hispanic Community Health Study/Study of LatinosPaul D Sorlie, Larissa M Avilés-Santa, Sylvia Wassertheil-Smoller, et al.American Journal of Respiratory and Critical Care Medicine|October 10, 2015
Pulmonary Disease and Age at Immigration among Hispanics. Results from the Hispanic Community Health Study/Study of LatinosR Graham Barr, Larissa Avilés-Santa, Sonia M Davis, et al.Clinical Pharmacology and Therapeutics|February 24, 2018
Considerations for Developing Targeted Therapies in Low-Frequency Molecular Subsets of a DiseaseRobert N Schuck, Janet Woodcock, Issam Zineh, et al.Journal of Clinical and Translational Science|December 2, 2024
Erratum: The statistical design and analysis of pandemic platform trials: Implications for the future - CORRIGENDUMChristopher J Lindsell, Matthew Shotwell, Kevin J Anstrom, et al.Journal of Clinical and Translational Science|November 14, 2024
The statistical design and analysis of pandemic platform trials: Implications for the futureChristopher J Lindsell, Matthew Shotwell, Kevin J Anstrom, et al.JAMA|November 3, 2012
Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the United StatesMartha L Daviglus, Gregory A Talavera, M Larissa Avilés-Santa, et al.Journal of Clinical and Translational Science|October 31, 2024
ACTIV trials: Lessons learned in trial design in the setting of an emergent pandemicMaryam Keshtkar-Jahromi, Kevin J Anstrom, Christina Barkauskas, et al.NEJM Evidence|October 22, 2024
Lessons Learned from National Heart, Lung, and Blood Institute Covid-19 Clinical TrialsSonia M Thomas, Robert A Harrington, Clyde W Yancy, et al.Pain Medicine (Malden, Mass.)|January 9, 2023
The Back Pain Consortium (BACPAC) Research Program: Structure, Research Priorities, and MethodsMatthew C Mauck, Jeffrey Lotz, Matthew A Psioda, et al.Medrxiv : the Preprint Server for Health Sciences|September 29, 2022
Infliximab for Treatment of Adults Hospitalized with Moderate or Severe Covid-19Jane A O'Halloran, Eyal Kedar, Kevin J Anstrom, et al.Pageof 3